Report Categories
View AllRecent Articles
View All
How sustainable is Yorkville MCGAW earnings momentum
SEVN Seven reports narrow Q1 2026 EPS beat shares rise nearly 2 percent on upbeat investor reaction
Crescent FCRX Business Update
OXLCO Oxford posts 74 Q4 2025 EPS miss shares edge 058 lower in todays trading session
Redwire Corporations Ascent Space Sector Momentum and Contract Wins Drive Investor Interest
Dell Shares Surge on 97 Billion Pentagon Deal Q1 Earnings Expectations in Focus
ADP Private Payrolls Surge Past Expectations in April Signaling Stable Labor Market
Jim Cramer Expresses Disappointment Over Toll Brothers Amid Housing Headwinds
Softtech Engineers Stock at Key Breakout Level Market Eyes 470 Resistance
Markets Price Out Rate Cuts Until 2027 After Hot Inflation Report
Acacia Research Corporation ACTG Q1 2026 Earnings Significant EPS Miss Amidst Uncertain Revenue Landscape
AWI Q1 2026 Earnings EPS Falls Short as Revenue Picture Remains Unclear
LXP Industrial Trust Q1 2026 Earnings EPS Misses Estimates Amid Resilient Operational Trends
Cosmos Health Inc Q1 2026 Earnings Deep EPS Miss Raises Concerns Amid Thin Revenue Disclosure
VLYPP Q1 2026 Earnings EPS Beats Consensus by 507 as Stock Slips 029
PMTW Q1 2026 Earnings Significant EPS Miss as Trust Reports 016 vs 038 Estimate
PureCycle Technologies PCT Holds Steady Near Support as Volume Remains Subdued
Euro Tech Holdings CLWT Stability at 122 as Support and Resistance Boundaries Tighten
Riskified Ltd RSKD Slips 252 as Stock Tests Key Support Levels
Natuzzi SpA NTZ Holds Steady at 255 as Traders Eye Resistance
Culp Inc CULP Holds Steady Near Support as Traders Eye Key Resistance
EXP Q1 2026 Earnings Powerful EPS Beat Highlights Cost Discipline Amid Subdued Demand
OOMA Q1 2026 Earnings EPS Surpasses Estimates by 929
Evommune Inc EVMN Q1 2026 Earnings EPS Beats Estimates as PreRevenue Biotech Focuses on Pipeline Progress
Franklin BSP Realty Trust Inc FBRT Q1 2026 Earnings EPS Misses Estimates Amid Challenging Commercial Real Estate Climate
GWRE Q1 2026 Earnings Strong EPS Beat Drives Stock Higher
VIR Q1 2026 Earnings Significant EPS Miss as Biotech Continues Investment Phase